Роберто Пили
Memorial Sloan Kettering Cancer Center(US)Jacobs Institute(US)Jacobs (United States)(US)University at Buffalo, State University of New York(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Renal and related cancers
Most-Cited Works
- → Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma(2009)2,185 cited
- A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.(1992)
- → Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial(2016)631 cited
- → Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth(2008)611 cited
- → Consensus guidelines for the use and interpretation of angiogenesis assays(2018)588 cited
- → Kidney Cancer(2009)470 cited
- →